Tandem Diabetes Care, Inc. TNDM
Set alert
As of Nov 2, 10:39 AM ET
- YTD
- -13.83%
- 1 year
- +35.29%
- Open
- 19.35
- Prev close
- 19.11
- Mkt cap
- 1.32B
- Vol
- 158.23K
- Avg vol
- 2.14M
- EPS
- -0.91
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 18.84
- High
- 19.45
- Forward P/E
- 120.22
- Beta
- 1.66
- Short ratio
- 6.27
- Inst. own
- 115.75%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 18.09
- 200-d avg
- 18.94
- 1y target
- 27.76
3M chart
Events in this range
- Aug 6, 2026Earnings: -0.31; estimate -0.32074; surprise 3.35%
- Aug 7, 2026Rating: RBC Capital · Outperform → Outperform
- Aug 7, 2026Rating: Citigroup · Neutral → Neutral
- Aug 21, 2026Rating: William Blair · — → Outperform
- Sep 24, 2026Rating: Truist Securities · Buy → Buy
- Sep 30, 2026Rating: Citigroup · Neutral → Neutral
- Oct 7, 2026Rating: Barclays · — → Equal-Weight
Signals (11)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 26, 2026 | 1 week ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 2, 2026 | 1 month ago |
| RSI: Oversold | Sep 24, 2026 | 1 month ago |
| RSI: Oversold | Sep 11, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Sep 2, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 21, 2026 | 2 months ago |
| RSI: Overbought | Aug 18, 2026 | 2 months ago |
| RSI: Overbought | Aug 7, 2026 | 2 months ago |
| RSI: Overbought | Aug 3, 2026 | 3 months ago |
Key statistics
- Market cap
- 1.33B
- Enterprise value
- 1.66B
- Trailing P/E
- 0.00
- Forward P/E
- 120.22
- PEG ratio
- 0.00
- Price / sales
- 1.28
- Price / book
- 10.19
- EPS (TTM)
- -0.91
- Beta
- 1.66
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -6.08%
- Revenue (TTM)
- 1.04B
- Revenue growth
- 5.80%
- Free cash flow
- -43.95M
- Total cash
- 456.00M
- Total debt
- 739.25M
- Return on equity
- -48.03%
- Shares outstanding
- 69.58M
- Short % of float
- 29.04%
- 50-day average
- 18.09
- 200-day average
- 18.94
Analyst view
Consensus: buy
- Target (low)
- 18.00
- Target (mean)
- 27.76
- Target (high)
- 50.00
- Strong buy2
- Buy11
- Hold12
- Sell0
- Strong sell0
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate -0.2402.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Sep 30, 2026 | -0.24533 | — | — | — |
| Aug 6, 2026 | Jun 30, 2026 | -0.32074 | -0.31 | +0.01 | +3.35% |
| May 7, 2026 | Mar 31, 2026 | -0.46 | -0.30 | +0.16 | +34.78% |
| Feb 19, 2026 | Dec 31, 2025 | -0.05 | -0.01 | +0.04 | +80.00% |
| Nov 6, 2025 | Sep 30, 2025 | -0.31 | -0.31 | 0.00 | 0.00% |
| Aug 6, 2025 | Jun 30, 2025 | -0.40 | -0.48 | -0.08 | -20.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 7, 2026 | Barclays | init | — | Equal-Weight |
| Sep 30, 2026 | Citigroup | main | Neutral | Neutral |
| Sep 24, 2026 | Truist Securities | main | Buy | Buy |
| Aug 21, 2026 | William Blair | init | — | Outperform |
| Aug 7, 2026 | Citigroup | main | Neutral | Neutral |
| Aug 7, 2026 | RBC Capital | main | Outperform | Outperform |
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- tandemdiabetes.com
News
- Tandem Diabetes Care Announces Upcoming Conference Presentations
- Tandem Diabetes Care, Inc. (TNDM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
- Tandem Diabetes Care Q2 2026 Earnings Call Transcript
- Barclays Initiates Coverage On Tandem Diabetes Care with Equal-Weight Rating, Announces Price Target of $18
- Citigroup Maintains Neutral on Tandem Diabetes Care, Lowers Price Target to $20
- FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking
- William Blair Initiates Coverage On Tandem Diabetes Care with Outperform Rating
- Innovative Insulin Pumps Drive Optimism for Tandem, Beta Bionics
- Airsculpt Technologies, Barrick Mining And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
- Citigroup Maintains Neutral on Tandem Diabetes Care, Raises Price Target to $21
Your note
Sign in to keep a note on TNDM — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALLEN DICK P | Retired | Conversion of Exercise of derivative security | May 20, 2026 | 50,903 |
| BLICKENSTAFF KIM D | Director | Sale | Nov 20, 2024 | 0 |
| CARPENTER RICK | Chief Technology Officer | Conversion of Exercise of derivative security | Aug 13, 2026 | 32,148 |
| GASSER ELIZABETH ANNE | Officer | Conversion of Exercise of derivative security | Aug 13, 2026 | 34,505 |
| HANSEN SHANNON MARIE | Officer | Conversion of Exercise of derivative security | Aug 13, 2026 | 33,585 |
| MORRISON SUSAN M | Officer | Conversion of Exercise of derivative security | Aug 13, 2026 | 52,788 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 16.65% | 11,583,125 | 221.35M | Jun 29, 2026 |
| Sessa Capital IM, L.P. | 7.33% | 5,100,000 | 97.46M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 6.18% | 4,299,667 | 82.17M | Jun 29, 2026 |
| First Light Asset Management, LLC | 4.86% | 3,383,553 | 64.66M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.45% | 3,096,536 | 59.17M | Jun 29, 2026 |
| State Street Corporation | 4.10% | 2,851,646 | 54.49M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.95% | 4,140,278 | 79.12M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.14% | 2,186,918 | 41.79M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.59% | 1,803,947 | 34.47M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.26% | 1,570,019 | 30.00M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.30% | 901,467 | 17.23M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.13% | 788,509 | 15.07M | Jun 29, 2026 |